» Articles » PMID: 11266506

Synergistic Activation of the Serotonin-1A Receptor by Nuclear Factor-kappa B and Estrogen

Overview
Journal Mol Endocrinol
Date 2001 Mar 27
PMID 11266506
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen exerts profound effects on mood and mental state. The ability of estrogen to modulate serotonergic function raises the possibility that it may play a role in the mechanism associated with depression and its treatment. A cellular mechanism for estrogen to influence mood might be through the regulation of genes involved at various levels of the serotonin system. Here we report that estrogen can up-regulate the expression of the serotonin-1A receptor via a new mechanism involving synergistic activation by nuclear factor-kappa B (NF-kappa B) with estrogen receptor alpha. Interestingly, we observed that only estrogen receptor-alpha, and not -beta, was able to mediate this effect of estrogens. The partial antiestrogen, 4-hydroxytamoxifen, had the same effect as estrogen. In addition, mutation analysis showed that both the transactivation function of p65 and activation function 1 of estrogen receptor-alpha were essential for this synergistic regulation. Therefore, we propose that NF-kappa B complexes cooperate with estrogen receptor-alpha to recruit cofactors into the complex and thereby synergistically activate the serotonin-1A receptor promoter through nonclassical estrogen response elements by a mechanism that does not involve direct receptor binding to DNA.

Citing Articles

Estrogen deficiency reduces maximal running capacity and affects serotonin levels differently in the hippocampus and nucleus accumbens in response to acute exercise.

Lee E, Nissinen T, Yla-Outinen L, Jalkanen A, Karppinen J, Vieira-Potter V Front Neurosci. 2024; 18:1399229.

PMID: 38983274 PMC: 11231437. DOI: 10.3389/fnins.2024.1399229.


The impact of estradiol on serotonin, glutamate, and dopamine systems.

Bendis P, Zimmerman S, Onisiforou A, Zanos P, Georgiou P Front Neurosci. 2024; 18:1348551.

PMID: 38586193 PMC: 10998471. DOI: 10.3389/fnins.2024.1348551.


Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR.

Jamu I, Okamoto H Front Glob Womens Health. 2023; 3:1012463.

PMID: 36619589 PMC: 9812521. DOI: 10.3389/fgwh.2022.1012463.


Estrogen modulation of the pronociceptive effects of serotonin on female rat trigeminal sensory neurons is timing dependent and dosage dependent and requires estrogen receptor alpha.

Kaur S, Hickman T, Lopez-Ramirez A, McDonald H, Lockhart L, Darwish O Pain. 2022; 163(8):e899-e916.

PMID: 35121697 PMC: 9288423. DOI: 10.1097/j.pain.0000000000002604.


Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women.

Larsen S, Kohler-Forsberg K, Dam V, Poulsen A, Svarer C, Jensen P Acta Psychiatr Scand. 2020; 142(4):294-306.

PMID: 33314049 PMC: 7586815. DOI: 10.1111/acps.13211.